John Harrington
Net worth: 163 $ as of 2024-03-30
Profile
John J.
Harrington is the founder of Athersys, Inc. which was founded in 1995.
He held the title of Director, Chief Scientific Officer & Executive VP from 1995 to 2022.
He also founded Athersys, Inc. in 2007.
Dr. Harrington's former job was as Chief Scientific Officer & EVP at BTHC VI, Inc. Dr. Harrington received a doctorate degree from Stanford University and an undergraduate degree from the University of California San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ATHERSYS, INC.
0.04% | 2023-08-13 | 27,169 ( 0.04% ) | 163 $ | 2024-03-30 |
Former positions of John Harrington
| Companies | Position | End |
|---|---|---|
| ATHERSYS, INC. | Founder | 2022-06-15 |
| BTHC VI, Inc. | Chief Tech/Sci/R&D Officer | 2007-09-05 |
Athersys, Inc. /Old/
 Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Founder | 2007-06-07 |
Training of John Harrington
| Stanford University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Athersys, Inc. /Old/
Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Athersys, Inc. manufactures & markets pharmaceutical products and is engaged in the development and commercialization of therapeutic products to treat significant and life-threatening diseases. The company has three primary focus areas, which include: regenerative medicine (applying the MultiStem, cell therapy platform), medicinal chemistry & pharmacology genomics. It was founded in December 1995 and is headquartered at Cleveland, OH. | Health Technology |
| BTHC VI, Inc. | Finance |
- Stock Market
- Insiders
- John Harrington
